Ask AI

Shaping the Future of ALL: Advancing Novel Immune-Targeted Therapies to Address Unmet Clinical Needs

Hematologists and oncologists will gain in-depth knowledge on novel T-cell engager therapies, including their mechanism of action, safety, and efficacy, in acute lymphoblastic leukemia and identify patients who may be eligible for enrollment on clinical trials evaluating these immune-targeted therapies through an expert-written ClinicalThought commentary, an on-demand webcast, and downloadable slides. 

Share

Program Content

Activities

T Cell Engagers in ALL
Approved and Emerging T-Cell Engagers in ALL
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: June 25, 2025

Expires: December 24, 2025

CAR T Cell Therapies in ALL
Approved and Emerging CAR T-Cell Therapies in ALL
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: June 25, 2025

Expires: December 24, 2025

Activities

Immune Targeted Therapies in ALL
Shaping the Future of ALL: Advancing Novel Immune-Targeted Therapies to Address Unmet Clinical Needs
Video
Congratulations: You achieved a completion on 04/09/2022

Released: July 07, 2025

Expires: January 06, 2026

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC

Supporters

Supported by an educational grant from AstraZeneca.

AstraZeneca